Pfizer

Content by Pfizer

|3 min read

Positive Results from Trial of COVID-19 Vaccine in Children Five to 11 Years

Pfizer Inc. and BioNTech SE announced results from a Phase 2/3 trial showing a favorable safety profile
Page 1 of 1